{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:37:31Z","timestamp":1793777851506,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1245\/s10434-016-5108-4","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T12:44:26Z","timestamp":1454417066000},"page":"592-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC)"],"prefix":"10.1245","volume":"23","author":[{"given":"Tinatin","family":"Kakchekeeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Demtr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmitha I.","family":"Herath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Torkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Sola\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dutreix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,2]]},"reference":[{"key":"5108_CR1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumors (review). Nat Rev Cancer. 2006;6:583\u201392.","journal-title":"Nat Rev Cancer."},{"key":"5108_CR2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archsurg.2007.49","volume":"143","author":"R Steinert","year":"2008","unstructured":"Steinert R, Hantschick M, Vieth M, et al. Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer. Arch Surg. 2008;143:122\u20138.","journal-title":"Arch Surg."},{"key":"5108_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","volume":"7","author":"WP Ceelen","year":"2010","unstructured":"Ceelen WP, Flessner MF. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol. 2010;7:108\u201315.","journal-title":"Nat Rev Clin Oncol."},{"key":"5108_CR4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","volume":"89","author":"RL Dedrick","year":"1997","unstructured":"Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997;89:480\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"5108_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004649900010","volume":"14","author":"MA Reymond","year":"2000","unstructured":"Reymond MA, Hu B, Garcia A, et al. Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc. 2000;14:51\u20135.","journal-title":"Surg Endosc."},{"key":"5108_CR6","unstructured":"Haidira A, Pocard M. Nouveau mode d\u2019administration en intrap\u00e9riton\u00e9al d\u2019une chimioth\u00e9rapie dans le traitement de la carcinose p\u00e9riton\u00e9ale: PIPAC (pressurized intraperitoneal aerosol chemotherapy). Master\u2019s thesis, University of Paris, 2015."},{"key":"5108_CR7","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Sola\u00df","year":"2012","unstructured":"Sola\u00df W, Hetzel A, Nadiradze G, et al. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849\u201355.","journal-title":"Surg Endosc."},{"key":"5108_CR8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Herbette A, Schwarz T, et al. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc. 2012;26:847\u201352.","journal-title":"Surg Endosc."},{"key":"5108_CR9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, M\u00fcrdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21:553\u20139.","journal-title":"Ann Surg Oncol."},{"key":"5108_CR10","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","volume":"20","author":"A Blanco","year":"2013","unstructured":"Blanco A, Giger-Pabst U, Solass W, Zieren J, Reymond MA. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol. 2013;20:2311\u20136.","journal-title":"Ann Surg Oncol."},{"key":"5108_CR11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","volume":"132","author":"CB Tempfer","year":"2014","unstructured":"Tempfer CB, Celik I, Solass W, et al. Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Gynecol Oncol. 2014;132:307\u201311.","journal-title":"Gynecol Oncol."},{"key":"5108_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","volume":"20","author":"G Nadiradze","year":"2016","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg. 2016;20:367\u201373.","journal-title":"J Gastrointest Surg."},{"key":"5108_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/codi.13130","author":"C Demtr\u00f6der","year":"2015","unstructured":"Demtr\u00f6der C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2015. doi: 10.1111\/codi.13130 .","journal-title":"Colorectal Dis."},{"key":"5108_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","volume":"137","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Winnekendonk G, Horvat R, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: an open-label, single-arm, phase 2 study (PIPAC-OV1). Gynaecol Oncol. 2015;137:223\u20138.","journal-title":"Gynaecol Oncol."},{"key":"5108_CR15","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1093\/nar\/gkt522","volume":"41","author":"A Croset","year":"2013","unstructured":"Croset A, Cordeli\u00e8res FP, Berthault N, et al. Inhibition of DNA damage repair by artificial activation of PARP with siDNA. Nucleic Acids Res. 2013;41:7344\u201355.","journal-title":"Nucleic Acids Res."},{"key":"5108_CR16","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00464-014-3427-8","volume":"28","author":"J Ansell","year":"2014","unstructured":"Ansell J, Warren N, Wall P, et al. Electrostatic precipitation is a novel way of maintaining visual field clarity during laparoscopic surgery: a prospective double-blind randomized controlled pilot study. Surg Endosc. 2014;28:2057\u201365.","journal-title":"Surg Endosc."},{"key":"5108_CR17","unstructured":"Alesi Surgical, Cardiff, UK. Available at: http:\/\/www.alesi-surgical.com\/ . Accessed April 29, 2015."},{"key":"5108_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","volume":"8","author":"T Helleday","year":"2008","unstructured":"Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008;8:193\u2013204.","journal-title":"Nat Rev Cancer."},{"key":"5108_CR19","doi-asserted-by":"crossref","first-page":"e20594","DOI":"10.1371\/journal.pone.0020594","volume":"6","author":"KO Vasquez","year":"2011","unstructured":"Vasquez KO, Casavant C, Peterson JD. Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging. PLoS One. 2011;6:e20594.","journal-title":"PLoS One."},{"key":"5108_CR20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","volume":"40","author":"D Elias","year":"2014","unstructured":"Elias D, Mariani A, Cloutier AS, et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol. 2014;40:1467\u201373.","journal-title":"Eur J Surg Oncol."},{"key":"5108_CR21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","volume":"50","author":"D Elias","year":"2014","unstructured":"Elias D, Go\u00e9r\u00e9 D, Dumont F, et al. Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer. 2014;50:332\u201340.","journal-title":"Eur J Cancer."},{"key":"5108_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2482-14-57","volume":"14","author":"K Takebayashi","year":"2014","unstructured":"Takebayashi K, Sonoda H, Shimizu T, et al. Successful surgical approach for a patient with encapsulating peritoneal sclerosis after hyperthermic intraperitoneal chemotherapy: a case report and literature review. BMC Surg. 2014;14:57.","journal-title":"BMC Surg."},{"key":"5108_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1479-828X.2010.01230.x","volume":"51","author":"WS Chan","year":"2011","unstructured":"Chan WS, Bohmer R, McIntosh R, Blomfield P. Peritoneal fibrosis leading to small bowel obstruction two years after first-line intraperitoneal chemotherapy for optimally debulked ovarian cancer. Aust N Z J Obstet Gynaecol. 2011;51:91\u20132.","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"5108_CR24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s005950300052","volume":"33","author":"H Aihara","year":"2003","unstructured":"Aihara H, Maruoka H, Kiyozaki H, Konishi F. Sclerosing encapsulating peritonitis (SEP) as a delayed complication of continuous hyperthermic peritoneal perfusion (CHPP): report of a case. Surg Today. 2003;33:232\u20136.","journal-title":"Surg Today."},{"key":"5108_CR25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00686012","volume":"29","author":"LT Vlasveld","year":"1992","unstructured":"Vlasveld LT, Taal BG, Kroon BB, Gallee MP, Rodenhuis S. Intestinal obstruction due to diffuse peritoneal fibrosis at 2\u00a0years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone. Cancer Chemother Pharmacol. 1992;29:405\u20138.","journal-title":"Cancer Chemother Pharmacol."},{"issue":"Suppl 3","key":"5108_CR26","doi-asserted-by":"crossref","first-page":"S588","DOI":"10.1245\/s10434-015-4580-6","volume":"22","author":"P Wagner","year":"2015","unstructured":"Wagner P, Boone B, Ramalingam L, et al. Histologic and immunohistochemical alterations associated with cytoreductive surgery and heated intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22(Suppl 3):S588\u201395.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5108-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5108-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T11:35:22Z","timestamp":1553600122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,2]]},"references-count":26,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["5108"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5108-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,2]]}}}